NEXT PI Spira — Fairfax, Virginia

NEXT PI Spira is a clinical research site located in Fairfax, Virginia, United States 22031.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

NEXT PI Spira has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Advanced Solid Tumor, Metastatic Solid Tumor.

Sponsors: Ipsen.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Fairfax

Browse all research sites in Virginia · View every site in Fairfax

• USOR - VA Cancer Specialists
• Inova Outpatient Surgery Clinic and Inova Fairfax Hospital
• Inova Fairfax Hospital - Fairfax
• Inova Schar Cancer Institute Dept of Fairfax Hospital
• Inova Fairfax Hospital For Children
• Inova Fairfax Hospital Cancer Center
• US Oncology - Fairfax-Northern VA Hem-Onc PC
• INOVA Fairfax Hospital
• George Mason University
• Pediatric Specialty of VA /ID# 142831
• George Mason University Department of Psychology
• Inova Fair Oaks Hospital

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for NEXT PI Spira?

NEXT PI Spira has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has NEXT PI Spira conducted?

NEXT PI Spira has 1 clinical trials on record, with 1 currently active. Their work covers Advanced Solid Tumor, Metastatic Solid Tumor.

Is NEXT PI Spira accredited by Crixeo Clinical Trials?

NEXT PI Spira has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about NEXT PI Spira?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.